4.7 Article

DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes

期刊

AMERICAN JOURNAL OF HUMAN GENETICS
卷 106, 期 5, 页码 596-610

出版社

CELL PRESS
DOI: 10.1016/j.ajhg.2020.03.008

关键词

-

资金

  1. Canadian Institutes of Health Research (CIHR) [IGH-155182, MOP-126054]
  2. CIHR Project Grant [PJT-148830]
  3. BCCHR intramural IGAP salary award
  4. Canadian Centre for Computational Genomics (C3G)
  5. Genome Technology Platform (GTP) - Genome Canada through Genome Quebec and Ontario Genomics
  6. Genome Canada through Ontario Genomics
  7. Ontario Brain Institute (OBI)
  8. Ontario government
  9. Telethon Foundation [GEP13105]
  10. EPI GEN Flagship Project of the Italian National Research Council
  11. European Research Council [616441-DISEASEAVATARS]
  12. Italian Ministry of Health

向作者/读者索取更多资源

Weaver syndrome (WS), an overgrowth/intellectual disability syndrome (OGID), is caused by pathogenic variants in the histone methyl-transferase EZH2, which encodes a core component of the Polycomb repressive complex-2 (PRC2). Using genome-wide DNA methylation (DNAm) data for 187 individuals with OGID and 969 control subjects, we show that pathogenic variants in EZH2 generate a highly specific and sensitive DNAm signature reflecting the phenotype of WS. This signature can be used to distinguish loss-of-function from gain-of-function missense variants and to detect somatic mosaicism. We also show that the signature can accurately classify sequence variants in EED and SUZ12, which encode two other core components of PRC2, and predict the presence of pathogenic variants in undiagnosed individuals with OGID. The discovery of a functionally relevant signature with utility for diagnostic classification of sequence variants in EZH2, EED, and SUZ12 supports the emerging paradigm shift for implementation of DNAm signatures into diagnostics and translational research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据